The global market for Short Sleep Syndrome Treatment was valued at US$ 10250 million in the year 2024 and is projected to reach a revised size of US$ 18580 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Short Sleep Syndrome Treatment Market

Short Sleep Syndrome is a sleep condition characterized by sleeping for fewer than six hours each night . Most adults need seven or more hours of sleep each night to feel rested in the morning.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Short Sleep Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Short Sleep Syndrome Treatment.

The Short Sleep Syndrome Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Short Sleep Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Short Sleep Syndrome Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Short Sleep Syndrome Treatment Market Report

Report Metric	Details
Report Name	Short Sleep Syndrome Treatment Market
Accounted market size in year	US$ 10250 million
Forecasted market size in 2031	US$ 18580 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Benzodiazepines Nonbenzodiazepines Antidepressants Orexin Antagonist Melatonin Antagonist Other
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & co., Mylan N.V., Paratek pharmaceuticals, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon pharma Co. Ltd., Takeda Pharmaceuticals Company Ltd., Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Short Sleep Syndrome Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Short Sleep Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Short Sleep Syndrome Treatment Market growing?

Ans: The Short Sleep Syndrome Treatment Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Short Sleep Syndrome Treatment Market size in 2031?

Ans: The Short Sleep Syndrome Treatment Market size in 2031 will be US$ 18580 million.

Who are the main players in the Short Sleep Syndrome Treatment Market report?

Ans: The main players in the Short Sleep Syndrome Treatment Market are Merck & co., Mylan N.V., Paratek pharmaceuticals, Pfizer Inc., Sanofi S.A., Sumitomo Dainippon pharma Co. Ltd., Takeda Pharmaceuticals Company Ltd., Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.

What are the Application segmentation covered in the Short Sleep Syndrome Treatment Market report?

Ans: The Applications covered in the Short Sleep Syndrome Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Short Sleep Syndrome Treatment Market report?

Ans: The Types covered in the Short Sleep Syndrome Treatment Market report are Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonist, Melatonin Antagonist, Other

1 Short Sleep Syndrome Treatment Market Overview

1.1 Product Definition

1.2 Short Sleep Syndrome Treatment by Type

1.2.1 Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2024 VS 2031)

1.2.2 Benzodiazepines

1.2.3 Nonbenzodiazepines

1.2.4 Antidepressants

1.2.5 Orexin Antagonist

1.2.6 Melatonin Antagonist

1.2.7 Other

1.3 Short Sleep Syndrome Treatment by Application

1.3.1 Global Short Sleep Syndrome Treatment Market Value by Application (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Short Sleep Syndrome Treatment Market Size Estimates and Forecasts

1.4.1 Global Short Sleep Syndrome Treatment Revenue 2020-2031

1.4.2 Global Short Sleep Syndrome Treatment Sales 2020-2031

1.4.3 Global Short Sleep Syndrome Treatment Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Short Sleep Syndrome Treatment Market Competition by Manufacturers

2.1 Global Short Sleep Syndrome Treatment Sales Market Share by Manufacturers (2020-2025)

2.2 Global Short Sleep Syndrome Treatment Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Short Sleep Syndrome Treatment Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Short Sleep Syndrome Treatment, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Short Sleep Syndrome Treatment, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Short Sleep Syndrome Treatment, Product Type & Application

2.7 Global Key Manufacturers of Short Sleep Syndrome Treatment, Date of Enter into This Industry

2.8 Global Short Sleep Syndrome Treatment Market Competitive Situation and Trends

2.8.1 Global Short Sleep Syndrome Treatment Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Short Sleep Syndrome Treatment Players Market Share by Revenue

2.8.3 Global Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Short Sleep Syndrome Treatment Market Scenario by Region

3.1 Global Short Sleep Syndrome Treatment Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Short Sleep Syndrome Treatment Sales by Region: 2020-2031

3.2.1 Global Short Sleep Syndrome Treatment Sales by Region: 2020-2025

3.2.2 Global Short Sleep Syndrome Treatment Sales by Region: 2026-2031

3.3 Global Short Sleep Syndrome Treatment Revenue by Region: 2020-2031

3.3.1 Global Short Sleep Syndrome Treatment Revenue by Region: 2020-2025

3.3.2 Global Short Sleep Syndrome Treatment Revenue by Region: 2026-2031

3.4 North America Short Sleep Syndrome Treatment Market Facts & Figures by Country

3.4.1 North America Short Sleep Syndrome Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Short Sleep Syndrome Treatment Sales by Country (2020-2031)

3.4.3 North America Short Sleep Syndrome Treatment Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Short Sleep Syndrome Treatment Market Facts & Figures by Country

3.5.1 Europe Short Sleep Syndrome Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Short Sleep Syndrome Treatment Sales by Country (2020-2031)

3.5.3 Europe Short Sleep Syndrome Treatment Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Short Sleep Syndrome Treatment Market Facts & Figures by Region

3.6.1 Asia Pacific Short Sleep Syndrome Treatment Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Short Sleep Syndrome Treatment Sales by Region (2020-2031)

3.6.3 Asia Pacific Short Sleep Syndrome Treatment Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Short Sleep Syndrome Treatment Market Facts & Figures by Country

3.7.1 Latin America Short Sleep Syndrome Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Short Sleep Syndrome Treatment Sales by Country (2020-2031)

3.7.3 Latin America Short Sleep Syndrome Treatment Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Short Sleep Syndrome Treatment Market Facts & Figures by Country

3.8.1 Middle East and Africa Short Sleep Syndrome Treatment Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Short Sleep Syndrome Treatment Sales by Country (2020-2031)

3.8.3 Middle East and Africa Short Sleep Syndrome Treatment Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Short Sleep Syndrome Treatment Sales by Type (2020-2031)

4.1.1 Global Short Sleep Syndrome Treatment Sales by Type (2020-2025)

4.1.2 Global Short Sleep Syndrome Treatment Sales by Type (2026-2031)

4.1.3 Global Short Sleep Syndrome Treatment Sales Market Share by Type (2020-2031)

4.2 Global Short Sleep Syndrome Treatment Revenue by Type (2020-2031)

4.2.1 Global Short Sleep Syndrome Treatment Revenue by Type (2020-2025)

4.2.2 Global Short Sleep Syndrome Treatment Revenue by Type (2026-2031)

4.2.3 Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2020-2031)

4.3 Global Short Sleep Syndrome Treatment Price by Type (2020-2031)

5 Segment by Application

5.1 Global Short Sleep Syndrome Treatment Sales by Application (2020-2031)

5.1.1 Global Short Sleep Syndrome Treatment Sales by Application (2020-2025)

5.1.2 Global Short Sleep Syndrome Treatment Sales by Application (2026-2031)

5.1.3 Global Short Sleep Syndrome Treatment Sales Market Share by Application (2020-2031)

5.2 Global Short Sleep Syndrome Treatment Revenue by Application (2020-2031)

5.2.1 Global Short Sleep Syndrome Treatment Revenue by Application (2020-2025)

5.2.2 Global Short Sleep Syndrome Treatment Revenue by Application (2026-2031)

5.2.3 Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2020-2031)

5.3 Global Short Sleep Syndrome Treatment Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck & co.

6.1.1 Merck & co. Company Information

6.1.2 Merck & co. Description and Business Overview

6.1.3 Merck & co. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck & co. Short Sleep Syndrome Treatment Product Portfolio

6.1.5 Merck & co. Recent Developments/Updates

6.2 Mylan N.V.

6.2.1 Mylan N.V. Company Information

6.2.2 Mylan N.V. Description and Business Overview

6.2.3 Mylan N.V. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mylan N.V. Short Sleep Syndrome Treatment Product Portfolio

6.2.5 Mylan N.V. Recent Developments/Updates

6.3 Paratek pharmaceuticals

6.3.1 Paratek pharmaceuticals Company Information

6.3.2 Paratek pharmaceuticals Description and Business Overview

6.3.3 Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Paratek pharmaceuticals Short Sleep Syndrome Treatment Product Portfolio

6.3.5 Paratek pharmaceuticals Recent Developments/Updates

6.4 Pfizer Inc.

6.4.1 Pfizer Inc. Company Information

6.4.2 Pfizer Inc. Description and Business Overview

6.4.3 Pfizer Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Inc. Short Sleep Syndrome Treatment Product Portfolio

6.4.5 Pfizer Inc. Recent Developments/Updates

6.5 Sanofi S.A.

6.5.1 Sanofi S.A. Company Information

6.5.2 Sanofi S.A. Description and Business Overview

6.5.3 Sanofi S.A. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Sanofi S.A. Short Sleep Syndrome Treatment Product Portfolio

6.5.5 Sanofi S.A. Recent Developments/Updates

6.6 Sumitomo Dainippon pharma Co. Ltd.

6.6.1 Sumitomo Dainippon pharma Co. Ltd. Company Information

6.6.2 Sumitomo Dainippon pharma Co. Ltd. Description and Business Overview

6.6.3 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product Portfolio

6.6.5 Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates

6.7 Takeda Pharmaceuticals Company Ltd.

6.7.1 Takeda Pharmaceuticals Company Ltd. Company Information

6.7.2 Takeda Pharmaceuticals Company Ltd. Description and Business Overview

6.7.3 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product Portfolio

6.7.5 Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates

6.8 Teva Pharmaceutical Industries Ltd.

6.8.1 Teva Pharmaceutical Industries Ltd. Company Information

6.8.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview

6.8.3 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product Portfolio

6.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

6.9 Vanda Pharmaceuticals Inc.

6.9.1 Vanda Pharmaceuticals Inc. Company Information

6.9.2 Vanda Pharmaceuticals Inc. Description and Business Overview

6.9.3 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product Portfolio

6.9.5 Vanda Pharmaceuticals Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Short Sleep Syndrome Treatment Industry Chain Analysis

7.2 Short Sleep Syndrome Treatment Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Short Sleep Syndrome Treatment Production Mode & Process Analysis

7.4 Short Sleep Syndrome Treatment Sales and Marketing

7.4.1 Short Sleep Syndrome Treatment Sales Channels

7.4.2 Short Sleep Syndrome Treatment Distributors

7.5 Short Sleep Syndrome Treatment Customer Analysis

8 Short Sleep Syndrome Treatment Market Dynamics

8.1 Short Sleep Syndrome Treatment Industry Trends

8.2 Short Sleep Syndrome Treatment Market Drivers

8.3 Short Sleep Syndrome Treatment Market Challenges

8.4 Short Sleep Syndrome Treatment Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Mylan N.V.

Paratek Pharmaceuticals

Pfizer Inc

Sanofi

Sumitomo Dainippon Pharma Co Ltd

Teva Pharmaceutical Industries Ltd

Vanda Pharmaceuticals, Inc.

Takeda Pharmaceuticals Company Ltd.

List of Tables

Table 1. Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Short Sleep Syndrome Treatment Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Short Sleep Syndrome Treatment Market Competitive Situation by Manufacturers in 2024

Table 4. Global Short Sleep Syndrome Treatment Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Short Sleep Syndrome Treatment Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Short Sleep Syndrome Treatment Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Short Sleep Syndrome Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Short Sleep Syndrome Treatment, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Short Sleep Syndrome Treatment, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Short Sleep Syndrome Treatment, Product Type & Application

Table 12. Global Key Manufacturers of Short Sleep Syndrome Treatment, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Short Sleep Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Sleep Syndrome Treatment as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Short Sleep Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Short Sleep Syndrome Treatment Sales by Region (2020-2025) & (K Units)

Table 18. Global Short Sleep Syndrome Treatment Sales Market Share by Region (2020-2025)

Table 19. Global Short Sleep Syndrome Treatment Sales by Region (2026-2031) & (K Units)

Table 20. Global Short Sleep Syndrome Treatment Sales Market Share by Region (2026-2031)

Table 21. Global Short Sleep Syndrome Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Short Sleep Syndrome Treatment Revenue Market Share by Region (2020-2025)

Table 23. Global Short Sleep Syndrome Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Short Sleep Syndrome Treatment Revenue Market Share by Region (2026-2031)

Table 25. North America Short Sleep Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Short Sleep Syndrome Treatment Sales by Country (2020-2025) & (K Units)

Table 27. North America Short Sleep Syndrome Treatment Sales by Country (2026-2031) & (K Units)

Table 28. North America Short Sleep Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Short Sleep Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Short Sleep Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Short Sleep Syndrome Treatment Sales by Country (2020-2025) & (K Units)

Table 32. Europe Short Sleep Syndrome Treatment Sales by Country (2026-2031) & (K Units)

Table 33. Europe Short Sleep Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Short Sleep Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Short Sleep Syndrome Treatment Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Short Sleep Syndrome Treatment Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Short Sleep Syndrome Treatment Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Short Sleep Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Short Sleep Syndrome Treatment Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Short Sleep Syndrome Treatment Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Short Sleep Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Short Sleep Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Short Sleep Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Short Sleep Syndrome Treatment Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Short Sleep Syndrome Treatment Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Short Sleep Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Short Sleep Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Short Sleep Syndrome Treatment Sales (K Units) by Type (2020-2025)

Table 51. Global Short Sleep Syndrome Treatment Sales (K Units) by Type (2026-2031)

Table 52. Global Short Sleep Syndrome Treatment Sales Market Share by Type (2020-2025)

Table 53. Global Short Sleep Syndrome Treatment Sales Market Share by Type (2026-2031)

Table 54. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2020-2025)

Table 57. Global Short Sleep Syndrome Treatment Revenue Market Share by Type (2026-2031)

Table 58. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2020-2025)

Table 59. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2026-2031)

Table 60. Global Short Sleep Syndrome Treatment Sales (K Units) by Application (2020-2025)

Table 61. Global Short Sleep Syndrome Treatment Sales (K Units) by Application (2026-2031)

Table 62. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2020-2025)

Table 63. Global Short Sleep Syndrome Treatment Sales Market Share by Application (2026-2031)

Table 64. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Short Sleep Syndrome Treatment Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2020-2025)

Table 67. Global Short Sleep Syndrome Treatment Revenue Market Share by Application (2026-2031)

Table 68. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2020-2025)

Table 69. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2026-2031)

Table 70. Merck & co. Company Information

Table 71. Merck & co. Description and Business Overview

Table 72. Merck & co. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Merck & co. Short Sleep Syndrome Treatment Product

Table 74. Merck & co. Recent Developments/Updates

Table 75. Mylan N.V. Company Information

Table 76. Mylan N.V. Description and Business Overview

Table 77. Mylan N.V. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Mylan N.V. Short Sleep Syndrome Treatment Product

Table 79. Mylan N.V. Recent Developments/Updates

Table 80. Paratek pharmaceuticals Company Information

Table 81. Paratek pharmaceuticals Description and Business Overview

Table 82. Paratek pharmaceuticals Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Paratek pharmaceuticals Short Sleep Syndrome Treatment Product

Table 84. Paratek pharmaceuticals Recent Developments/Updates

Table 85. Pfizer Inc. Company Information

Table 86. Pfizer Inc. Description and Business Overview

Table 87. Pfizer Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Inc. Short Sleep Syndrome Treatment Product

Table 89. Pfizer Inc. Recent Developments/Updates

Table 90. Sanofi S.A. Company Information

Table 91. Sanofi S.A. Description and Business Overview

Table 92. Sanofi S.A. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Sanofi S.A. Short Sleep Syndrome Treatment Product

Table 94. Sanofi S.A. Recent Developments/Updates

Table 95. Sumitomo Dainippon pharma Co. Ltd. Company Information

Table 96. Sumitomo Dainippon pharma Co. Ltd. Description and Business Overview

Table 97. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Sumitomo Dainippon pharma Co. Ltd. Short Sleep Syndrome Treatment Product

Table 99. Sumitomo Dainippon pharma Co. Ltd. Recent Developments/Updates

Table 100. Takeda Pharmaceuticals Company Ltd. Company Information

Table 101. Takeda Pharmaceuticals Company Ltd. Description and Business Overview

Table 102. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Takeda Pharmaceuticals Company Ltd. Short Sleep Syndrome Treatment Product

Table 104. Takeda Pharmaceuticals Company Ltd. Recent Developments/Updates

Table 105. Teva Pharmaceutical Industries Ltd. Company Information

Table 106. Teva Pharmaceutical Industries Ltd. Description and Business Overview

Table 107. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Teva Pharmaceutical Industries Ltd. Short Sleep Syndrome Treatment Product

Table 109. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates

Table 110. Vanda Pharmaceuticals Inc. Company Information

Table 111. Vanda Pharmaceuticals Inc. Description and Business Overview

Table 112. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Vanda Pharmaceuticals Inc. Short Sleep Syndrome Treatment Product

Table 114. Vanda Pharmaceuticals Inc. Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Short Sleep Syndrome Treatment Distributors List

Table 118. Short Sleep Syndrome Treatment Customers List

Table 119. Short Sleep Syndrome Treatment Market Trends

Table 120. Short Sleep Syndrome Treatment Market Drivers

Table 121. Short Sleep Syndrome Treatment Market Challenges

Table 122. Short Sleep Syndrome Treatment Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Short Sleep Syndrome Treatment

Figure 2. Global Short Sleep Syndrome Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Short Sleep Syndrome Treatment Market Share by Type: 2024 & 2031

Figure 4. Benzodiazepines Product Picture

Figure 5. Nonbenzodiazepines Product Picture

Figure 6. Antidepressants Product Picture

Figure 7. Orexin Antagonist Product Picture

Figure 8. Melatonin Antagonist Product Picture

Figure 9. Other Product Picture

Figure 10. Global Short Sleep Syndrome Treatment Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Short Sleep Syndrome Treatment Market Share by Application: 2024 & 2031

Figure 12. Hospital Pharmacies

Figure 13. Retail Pharmacies

Figure 14. Online Pharmacies

Figure 15. Global Short Sleep Syndrome Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Short Sleep Syndrome Treatment Market Size (2020-2031) & (US$ Million)

Figure 17. Global Short Sleep Syndrome Treatment Sales (2020-2031) & (K Units)

Figure 18. Global Short Sleep Syndrome Treatment Average Price (US$/Unit) & (2020-2031)

Figure 19. Short Sleep Syndrome Treatment Report Years Considered

Figure 20. Short Sleep Syndrome Treatment Sales Share by Manufacturers in 2024

Figure 21. Global Short Sleep Syndrome Treatment Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Short Sleep Syndrome Treatment Players: Market Share by Revenue in Short Sleep Syndrome Treatment in 2024

Figure 23. Short Sleep Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Short Sleep Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Short Sleep Syndrome Treatment Sales Market Share by Country (2020-2031)

Figure 26. North America Short Sleep Syndrome Treatment Revenue Market Share by Country (2020-2031)

Figure 27. United States Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Short Sleep Syndrome Treatment Sales Market Share by Country (2020-2031)

Figure 30. Europe Short Sleep Syndrome Treatment Revenue Market Share by Country (2020-2031)

Figure 31. Germany Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Short Sleep Syndrome Treatment Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Short Sleep Syndrome Treatment Revenue Market Share by Region (2020-2031)

Figure 38. China Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Short Sleep Syndrome Treatment Sales Market Share by Country (2020-2031)

Figure 46. Latin America Short Sleep Syndrome Treatment Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Short Sleep Syndrome Treatment Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Short Sleep Syndrome Treatment Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Short Sleep Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Short Sleep Syndrome Treatment by Type (2020-2031)

Figure 56. Global Revenue Market Share of Short Sleep Syndrome Treatment by Type (2020-2031)

Figure 57. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Short Sleep Syndrome Treatment by Application (2020-2031)

Figure 59. Global Revenue Market Share of Short Sleep Syndrome Treatment by Application (2020-2031)

Figure 60. Global Short Sleep Syndrome Treatment Price (US$/Unit) by Application (2020-2031)

Figure 61. Short Sleep Syndrome Treatment Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Sleep Disorders Treatment Services Market Research Report 2025

Sleep Disorder Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Sleep Wake Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Insomnia Therapy Market Research Report 2025

Non 24 hour Sleep wake Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Insomnia Monitoring Equipment Market Insights Forecast to 2030

Global Sleep Software Market Research Report 2024

Global Sleep Service Provider Market Research Report 2024

Sleep Health Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Home Sleep Apnea Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mouth Devices for Sleep Apnea Market Insights Forecast to 2030

Global Short acting Interferon Market Research Report 2024

Global Desynchronosis Treatment Market Insights Forecast to 2030

Global Time Zone Change Syndrome Treatment Market Insights Forecast to 2030

Idiopathic Hypersomnia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Jet Lag Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-5H251

Thu Jun 05 00:00:00 UTC 2025

Add to Cart

Global Melatonin Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23J15873

Tue Jun 03 00:00:00 UTC 2025

Add to Cart

Global Melatonin Receptor Agonists Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12L14987

Fri May 30 00:00:00 UTC 2025

Add to Cart

Global Sleep Apnea Diagnostic and Therapeutic Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-15F12960

Thu May 29 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Short Sleep Syndrome Treatment Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-15Y14330

Global Short Sleep Syndrome Treatment Market Research Report 2025

FEATURED COMPANIES

Short Sleep Syndrome Treatment Market Size

Short Sleep Syndrome Treatment Market

Report Scope

Scope of Short Sleep Syndrome Treatment Market Report

Core Chapters

FAQ for this report

How fast is Short Sleep Syndrome Treatment Market growing?

What is the Short Sleep Syndrome Treatment Market size in 2031?

Who are the main players in the Short Sleep Syndrome Treatment Market report?

What are the Application segmentation covered in the Short Sleep Syndrome Treatment Market report?

What are the Type segmentation covered in the Short Sleep Syndrome Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS